Indian authorities person stopped accumulation astatine a mill adjacent Delhi aft its cough syrups were linked to the deaths of immoderate 69 children successful Gambia.
Indian wellness authorities person halted each accumulation astatine the main mill of Maiden Pharmaceuticals adjacent New Delhi aft its cough syrups were linked to the deaths of dozens of children successful Gambia.
Anil Vij, the home minister of India's bluish Haryana state, said authorities inspected the Maiden installation 4 times this month and recovered 12 violations of bully practices.
Maiden Pharma sells its products domestically arsenic good arsenic exports to countries successful Asia, Africa and Latin America.
"Keeping this successful view, the full accumulation of the institution has been banned and announcement has besides been issued," Vij said.
Maiden Pharma has 2 other manufacturing plants successful Haryana state.
What is the cause institution accused of?
The World Health Organization (WHO) released a study past week saying that acold and cough syrups manufactured by Maiden Pharma whitethorn beryllium linked to the deaths of astatine slightest 66 children successful Gambia.
The WHO said that laboratory investigation of 4 Maiden products showed they had "unacceptable" amounts of perchance life-threatening contaminants that tin earnestly harm kidneys.
The Gambian wellness minister, Ahmadou Lamin Samateh, said implicit the play that the fig of children who died from terrible kidney harm had risen to 69.
The WHO besides issued a aesculapian merchandise alert past week, asking regulators to region the Indian company's goods from the market.
The drug company's manager has denied the accusation to the Indian press.
The Gambian police, successful a preliminary probe study connected Tuesday, said that the children's deaths from kidney harm were linked to cough syrups made successful India, without naming the company.
Police added that the medicinal syrup was imported via a US-based company.
India's Health Ministry said past week it was informed astir the WHO findings past period and it was waiting connected results of tests of each 4 Maiden products from a federal laboratory.
India was not licensed to merchantability the cause domestically, but was lone allowed to export them to Gambia, the Indian Health Ministry added.
rm/nm (Reuters, AFP, AP)
English (US)